Table 1

Estimated deaths prevented or postponed by medical or surgical treatments in Turkey in 2008
Number of deaths prevented or postponed Percentage of total reduction
Treatments Number of eligible patients Patients receiving treatment (%) Relative risk reduction (%) Mean case-fatality (%) Absolute risk reduction Best estimate Minimum estimate Maximum estimate Best estimate Minimum estimate Maximum estimate
Acute MI 91317 0.067 1677 684 3309 4.7 1.9 9.3
Community CPR 9132 100 0.05 0.067 0.055 443 283 638 1.2 0.8 1.8
Hospital CPR 2740 6 0.32 0.067 0.323 53 34 91 0.1 0.1 0.3
Thrombolysis 91317 29 0.26 0.067 0.014 316 130 656 0.9 0.4 1.8
Aspirin 91317 93 0.15 0.067 0.010 774 317 1420 2.2 0.9 4.0
Beta blocker 91317 70 0.04 0.067 0.003 143 59 296 0.4 0.2 0.8
ACE inhibitor 91317 61 0.07 0.067 0.005 228 93 466 0.6 0.3 1.3
Primary PTCA 91317 18 0.32 0.067 0.020 589 241 1221 1.6 0.7 3.4
Primary CABG 91317 9 0.20 0.067 0.013 112 40 231
MI treatments in 1995 subtracted -1244 -599 -2367 3.5 1.7 6.6
Unstable angina 639 364 1800 1.8 1.0 5.0
Aspirin & heparin 45658 50 0.33 0.053 0.017 316 129 655 0.9 0.4 1.8
Aspirin alone 45658 88 0.15 0.053 0.008 245 100 465 0.7 0.3 1.3
PG IIB/IIIA 45658 41 0.09 0.053 0.005 70 28 144 0.2 0.1 0.4
CABG surgery for UA 45658 13 0.43 0.053 0.023 107 44 221 0.3 0.1 0.6
PTCA for UA 45658 26 0.32 0.053 0.016 152 62 314 0.4 0.2 0.9
Secondary Prev Post AMI 759071 0.061 4548 1454 6509 12.7 4.1 18.2
Aspirin 759071 73 0.778 0.045 0.007 2170 711 3665 6.1 2.0 10.3
Beta blocker 759071 63 0.526 0.045 0.010 2052 672 3713 5.7 1.9 10.4
ACE inhibitor 759071 61 0.514 0.045 0.009 1771 580 3198 5.0 1.6 9.0
Statin 759071 3 0.757 0.045 0.010 1339 351 2767 3.7 1.0 7.7
Warfarin 759071 8 0.032 0.045 0.010 76 25 138 0.2 0.1 0.4
Secondary Prev Post CABG/PCI 275652 0.006 1752 575 4164 4.9 1.6 11.7
Aspirin 273379 97 0.15 0.017 0.003 496 162 1076 1.4 0.5 3.0
Beta blocker 273379 60 0.23 0.017 0.004 470 154 1167 1.3 0.4 3.3
ACE inhibitor 273379 54 0.20 0.017 0.003 366 120 909 1.0 0.3 2.5
Statin 273379 87 0.22 0.017 0.004 377 124 898 1.1 0.3 2.5
Warfarin 273379 2.2 0.22 0.017 0.004 18 6 44 0.1 0.0 0.1
Rehabilitation 273379 83 27 208 0.2 0.1 0.6
Chronic angina 3348 1105 8627 9.4 3.1 24.2
CABG surgery 1995-2008 103293 100 0.35 0.012 0.002 632 324 1093 1.8 0.9 3.1
CABG treatments in 1995 subtracted 103293 -6 -4 -8 0.0 0.0 -0.1
Angioplasty 1996-2000 103293 100 0.00 0.022 0.000 0 0 0 0.0 0.0 0.0
Aspirin in community 103293 78 0.15 0.012 0.001 2840 931 7066 8.0 2.6 19.8
Statins in community 103293 63 0.23 0.012 0.003 1517 398 4530 4.2 1.1 12.7
Hospital heart failure 46511 0.258 1025 306 2756 2.9 0.9 7.7
ACE inhibitor 46511 43 0.20 0.166 0.033 251 66 744 0.7 0.2 2.1
Beta blocker 46511 37 0.35 0.166 0.058 378 99 1121 1.1 0.3 3.1
Spironolactone 46511 40 0.30 0.166 0.051 510 167 1269 1.4 0.5 3.6
Aspirin 46511 68 0.15 0.166 0.025 428 140 1041 1.2 0.4 2.9
Community heart failure 424611 0.085 2338 747 5961 6.5 2.1 16.7
ACE inhibitor 70 0.20 0.085 0.013 479 126 1430 1.3 0.4 4.0
Beta blocker 70 0.35 0.085 0.030 986 323 2453 2.8 0.9 6.9
Spironolactone 25 0.31 0.085 0.030 883 289 2197 2.5 0.8 6.1
Aspirin 90 0.15 0.085 0.013 924 303 2299 2.6 0.8 6.4
Statins 40 0.00 0.085 0.000 0 0 0 0.0 0.0 0.0
Hypertension treatment 10029567 57 0.13 0.007 0.001 2153 356 4472 6.0 1.0 12.5
Statins for primary prevention 6133187 2 0.35 0.006 0.002 41 11 205 0.1 0.0 0.6
Total treatment 16671 5356 35362 47.0 15.1 100.0

Unal et al.

Unal et al. BMC Public Health 2013 13:1135   doi:10.1186/1471-2458-13-1135

Open Data